Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of HIgh-flow Therapy in Long-term Oxygen Therapy
Sponsor: Skane University Hospital
Summary
This is a registry-based, randomized, controlled clinical trial of the effect of added high-flow oxygen therapy (using the device Lumis HFT) during one year in people with long-term oxygen therapy (LTOT) for chronic obstructive pulmonary disease (COPD) or interstitial lung disease (ILD).
Official title: Effect of HIgh-flow Therapy in Long-term Oxygen Therapy (HILOT): A Multicenter, Registry-based, Randomized Clinical Trial
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
310
Start Date
2024-06-10
Completion Date
2028-12
Last Updated
2025-05-21
Healthy Volunteers
No
Conditions
Interventions
Added high-flow oxygen therapy
Added high-flow oxygen therapy using the device Lumis HFT during nighttime and at the patient's discretion daytime, with the usual care (low-flow oxygen therapy) the rest of the time.
Standard care
Standard care with low-flow oxygen therapy in accordance with clinical routine.
Locations (2)
Research Unit, Blekinge University of Technology
Karlskrona, Blekinge County, Sweden
Department of Heart, Lung and Clinical Physiology, Örebro University Hospital
Örebro, Sweden